ACELYRIN: Funding, Investors & Team (Oct 2026)
ACELYRIN is a biopharma company focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating the development and commercialization of promising drug candidates and by leveraging its expertise to rapidly advance these medicines to patients.
ACELYRIN has raised $300M across 1 funding round on record, the most recent a Series C of $300M announced in Sep 2022.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
ACELYRIN Company Profile and Key Stats
Latest funding round on record: Sep 2022.
ACELYRIN Funding Rounds
ACELYRIN Founders and Leadership Team
Contact details for the ACELYRIN team: 1 of 1 has an email address on file.
Start 14-day free trial →ACELYRIN Funding Compared to Other Biotechnology Startups
ACELYRIN's latest round of $300M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like ACELYRIN in Biotechnology and Los Angeles
Companies Similar to ACELYRIN
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
ACELYRIN Funding FAQs
What does ACELYRIN do?
ACELYRIN is a biopharma company focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating the development and commercialization of promising drug candidates and by leveraging its expertise to rapidly advance these medicines to patients.
How much funding has ACELYRIN raised?
ACELYRIN has raised $300M across 1 round on record. The most recent is a Series C of $300M announced in Sep 2022.
When did ACELYRIN last raise funding?
ACELYRIN's most recent funding round on record is a Series C of $300M, announced in Sep 2022.
Who founded ACELYRIN?
FundedIQ lists Robert Carey (Founder) at ACELYRIN.
Where is ACELYRIN headquartered?
ACELYRIN is based in Los Angeles, California, United States.
How many employees does ACELYRIN have?
ACELYRIN is in the 11-50 employee band.
How does ACELYRIN's funding compare to other Biotechnology startups?
ACELYRIN's latest round of $300M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's ACELYRIN Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ACELYRIN is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.